HERON THERAPEUTICS INC shareholders Q3 2023

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
STATE STREET CORP 2,401,562$2,473,6090.00%
MILLENNIUM MANAGEMENT LLC 76,692$78,9930.00%
New England Capital Financial Advisors LLC 475$4900.00%
SG Americas Securities, LLC 30,560$310.00%
PRICE T ROWE ASSOCIATES INC /MD/ 20,804$220.00%
Beaird Harris Wealth Management, LLC 148$1530.00%
MetLife Investment Management, LLC 53,564$55,1710.00%
NISA INVESTMENT ADVISORS, LLC 1,085$1,1180.00%
Nuveen Asset Management, LLC 91,752$94,5050.00%
AMERIPRISE FINANCIAL INC 277,538$285,8640.00%
TORONTO DOMINION BANK 9$90.00%
DEUTSCHE BANK AG\ 45,551$46,9180.00%
CITIGROUP INC 210$2170.00%
Clearstead Advisors, LLC 6,400$6,5920.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 983,009$1,012,4990.00%
GOLDMAN SACHS GROUP INC 605,806$623,9800.00%
MORGAN STANLEY 435,507$448,5720.00%
COMERICA BANK 495$5100.00%
Invesco Ltd. 58,695$60,4550.00%
AMALGAMATED BANK 15,518$160.00%
External links

This page lists HERON THERAPEUTICS INC's shareholders in Q3 2023. To view HERON THERAPEUTICS INC's shareholder history, click here.